Experts back tamoxifen for breast cancer prevention

Executive officer Kay Francis said the MOGA had been lobbying the TGA and the PBAC and was planning to work with a pharmaceutical sponsor of the drug, which is genericised, to try to get an extended indication approved. She said the issue was a priority for the organisation.